SOX9 and glioblastoma: Recent studies have reported that SOX9 is a key regulator of stemness in GBM, and high SOX9 expression results in drug resistance in various cancers, including TMZ resistance in GBM cells.[24, 25, 26, 43] We further detected the expression of SOX9 by qRT‐PCR.